Frustrated after countless failed diet and exercise attempts, 41 year-old Jessica Lenth from Hamburg has started putting money aside for a drug that she sees as a possible door to a life without obesity.
  • @[email protected]
    5•1 year ago

    I don’t understand why insurance and health plans are denying paying for Wegovy. They rather shell out far more money for treatment of complications and co-mprbidities related to obesity than pay for the drug now? It’s being penny-wise and pound-foolish.

    • southsamurai
      -1•1 year ago

      It’s still an off label use, from what I was told. That’s the excuse anyway, but it’s a common excuse for insurance refusals

      • @[email protected]
        3•1 year ago

        Wegovy is indicated for the treatment of obesity. It’s Ozempic that’s being used off-label for weight loss.

        • southsamurai
          1•1 year ago

          Ahhh, I got them mixed up. Thanks for the correction